24 HR isosorbide mononitrate 120 MG Extended Release Oral Tablet — RxCUI 311196
RxNorm drug concept · Semantic clinical drug
RxCUI 311196
Semantic clinical drug · SCD
● Current RxNorm concept 19 FDA products
30 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI311196
Official name24 HR isosorbide mononitrate 120 MG Extended Release Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asisosorbide mononitrate 120 MG 24HR Extended Release Oral Tablet
FDA products mapped19
Package NDCs mapped30
Reported Medicaid activity (SDUD)457,041 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Isosorbide: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Isosorbide is designed to prevent chest pain (angina) from starting in the first place, not to stop an attack that's already happening. It works by relaxing and widening your blood...
- What exactly does this medication do — will it stop my chest pain when it happens?
- Yes, headaches are very common when you first start isosorbide — they happen because the medication widens blood vessels, including in your head. The good news is that headaches us...
- I keep getting headaches since starting this — is that normal, and will it go away?
🕸️ Concept Web — How 24 HR isosorbide mononitrate 120 MG Extended Rel... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
24 HR isosorbide mononitrate 120 MG Extended Release Oral Tablet
RxCUI 311196 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Isosorbide
6057IN -
Isosorbide mononitrate
28004PIN
-
Isosorbide
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Isosorbide Extended Release Oral Tablet
631894SCDF -
Isosorbide mononitrate Extended Release Oral Tablet
2645939SCDFP -
Isosorbide Oral Product
1159759SCDG -
Isosorbide Pill
1159760SCDG -
Isosorbide mononitrate Oral Product
2662908SCDGP -
Isosorbide mononitrate Pill
2662275SCDGP -
Extended Release Oral Tablet
316945DF -
Oral Product
1151131DFG - +1 more in this family
-
Isosorbide Extended Release Oral Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Isosorbide mononitrate 120 MG
353420SCDC
-
Isosorbide mononitrate 120 MG
Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Isosorbide mononitrate 120 MG
SCDC · 353420 -
Isosorbide Extended Release Oral Tablet
SCDF · 631894 -
Isosorbide mononitrate Extended Release Oral Tablet
SCDFP · 2645939 -
Isosorbide Oral Product
SCDG · 1159759 -
Isosorbide Pill
SCDG · 1159760 -
Isosorbide mononitrate Oral Product
SCDGP · 2662908 -
Isosorbide mononitrate Pill
SCDGP · 2662275
📦 FDA Products & Package NDCs
19 products · 30 package NDCs
30 package NDCs map to RxCUI 311196 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 13668-0104-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-104-01) | ISOSORBIDE MONONITRATE | Torrent Pharmaceuticals Limited | 2011-06-03 |
| 13668-0104-05 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-104-05) | ISOSORBIDE MONONITRATE | Torrent Pharmaceuticals Limited | 2024-08-23 |
| 13668-0104-10 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-104-10) | ISOSORBIDE MONONITRATE | Torrent Pharmaceuticals Limited | 2011-06-03 |
| 13668-0105-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-105-01) | ISOSORBIDE MONONITRATE | Torrent Pharmaceuticals Limited | 2011-06-03 |
| 13668-0105-10 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-105-10) | ISOSORBIDE MONONITRATE | Torrent Pharmaceuticals Limited | 2011-06-03 |
| 13668-0106-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-106-01) | ISOSORBIDE MONONITRATE | Torrent Pharmaceuticals Limited | 2011-06-03 |
| 13668-0106-10 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-106-10) | ISOSORBIDE MONONITRATE | Torrent Pharmaceuticals Limited | 2011-06-03 |
| 42677-0305-01 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (42677-305-... | Isosorbide Mononitrate | Shandong New Time Pharmaceutical Co., Ltd. | 2024-02-08 |
| 42677-0306-01 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (42677-306-... | Isosorbide Mononitrate | Shandong New Time Pharmaceutical Co., Ltd. | 2024-02-08 |
| 42677-0307-01 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (42677-307-... | Isosorbide Mononitrate | Shandong New Time Pharmaceutical Co., Ltd. | 2022-04-29 |
| 42677-0307-02 | 600 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (42677-307... | Isosorbide Mononitrate | Shandong New Time Pharmaceutical Co., Ltd. | 2022-04-29 |
| 42799-0960-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (42799-960-01) | Isosorbide Mononitrate | Edenbridge Pharmaceuticals LLC. | 2023-07-01 |
| 50742-0175-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50742-175... | Isosorbide Mononitrate | Ingenus Pharmaceuticals, LLC | 2018-11-13 |
| 50742-0175-05 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (50742-175-05) | Isosorbide Mononitrate | Ingenus Pharmaceuticals, LLC | 2018-11-13 |
| 50742-0176-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50742-176... | Isosorbide Mononitrate | Ingenus Pharmaceuticals, LLC | 2018-11-13 |
| 50742-0176-05 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (50742-176-05) | Isosorbide Mononitrate | Ingenus Pharmaceuticals, LLC | 2018-11-13 |
| 50742-0177-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50742-177... | Isosorbide Mononitrate | Ingenus Pharmaceuticals, LLC | 2018-11-13 |
| 51407-0208-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51407-208... | Isosorbide Mononitrate | Golden State Medical Supply, Inc. | 2019-04-19 |
| 51407-0208-05 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (51407-208-05) | Isosorbide Mononitrate | Golden State Medical Supply, Inc. | 2019-04-19 |
| 51407-0209-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51407-209... | Isosorbide Mononitrate | Golden State Medical Supply, Inc. | 2019-04-19 |
| 51407-0209-05 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (51407-209-05) | Isosorbide Mononitrate | Golden State Medical Supply, Inc. | 2019-04-19 |
| 51407-0210-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51407-210... | Isosorbide Mononitrate | Golden State Medical Supply, Inc. | 2019-04-19 |
| 59651-0539-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (59651-539-01) | ISOSORBIDE MONONITRATE | Aurobindo Pharma Limited | 2022-11-07 |
| 59651-0539-05 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (59651-539-05) | ISOSORBIDE MONONITRATE | Aurobindo Pharma Limited | 2022-11-07 |
| 59651-0540-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (59651-540-01) | ISOSORBIDE MONONITRATE | Aurobindo Pharma Limited | 2022-11-07 |
| 59651-0540-05 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (59651-540-05) | ISOSORBIDE MONONITRATE | Aurobindo Pharma Limited | 2022-11-07 |
| 59651-0541-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (59651-541-01) | ISOSORBIDE MONONITRATE | Aurobindo Pharma Limited | 2022-11-07 |
| 62135-0586-90 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (62135-586-90) | Isosorbide Mononitrate | Chartwell RX, LLC | 2023-04-26 |
| 62135-0587-90 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (62135-587-90) | Isosorbide Mononitrate | Chartwell RX, LLC | 2023-04-26 |
| 62135-0588-90 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (62135-588-90) | Isosorbide Mononitrate | Chartwell RX, LLC | 2023-04-26 |
Observed labelers:
Torrent Pharmaceuticals Limited (7) ·
Aurobindo Pharma Limited (5) ·
Golden State Medical Supply, Inc. (5) ·
Ingenus Pharmaceuticals, LLC (5) ·
Shandong New Time Pharmaceutical Co., Ltd. (4) ·
Chartwell RX, LLC (3)
· +1 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.